GemPharmatech Co., Ltd. (SHA:688046)

China flag China · Delayed Price · Currency is CNY
15.37
+0.62 (4.20%)
Mar 6, 2026, 4:00 PM EST
-1.35%
Market Cap 6.21B
Revenue (ttm) 793.25M
Net Income (ttm) 144.40M
Shares Out 410.00M
EPS (ttm) 0.35
PE Ratio 43.26
Forward PE 40.55
Dividend 0.14 (0.91%)
Ex-Dividend Date Nov 20, 2025
Volume 4,392,340
Average Volume 3,902,280
Open 14.73
Previous Close 14.75
Day's Range 14.62 - 15.45
52-Week Range 10.44 - 20.50
Beta 0.61
RSI 35.26
Earnings Date Apr 23, 2026

About GemPharmatech

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other se... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 1,578
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688046
Full Company Profile

Financial Performance

In 2025, GemPharmatech's revenue was 793.25 million, an increase of 15.49% compared to the previous year's 686.84 million. Earnings were 144.40 million, an increase of 31.49%.

Financial Statements

News

There is no news available yet.